Immunology and Immunotoxicology Endpoints in Early Drug Development

Immunotoxicology assessment plays a large role in the drug development pipeline, especially for large molecules and biologics. Researchers in early drug development have a wide variety of immunologic assay methods available that can support research endpoints and offer opportunities for much clearer views into the efficacy and safety of a compound. Aric Frantz, DVM, PhD, and Amanda Lucchini, PhD, both from Labcorp Drug Development's Immunology and Immunotoxicology team, held a webinar where they discussed a number of immunologic assessment assays, such as immunophenotyping, TDAR and cell-based assays along with strategies available to drug development teams.